Sanbao Chai

1.2k total citations
49 papers, 935 citations indexed

About

Sanbao Chai is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Sanbao Chai has authored 49 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Sanbao Chai's work include Diabetes Treatment and Management (18 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diabetes Management and Research (6 papers). Sanbao Chai is often cited by papers focused on Diabetes Treatment and Management (18 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diabetes Management and Research (6 papers). Sanbao Chai collaborates with scholars based in China, United Kingdom and Canada. Sanbao Chai's co-authors include Feng Sun, Zhirong Yang, Shanshan Wu, Yuan Zhang, Siyan Zhan, Linong Ji, Lishi Li, Xiaomei Zhang, Kai Yu and Linong Ji and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Life Sciences.

In The Last Decade

Sanbao Chai

46 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sanbao Chai China	17	582	289	212	171	151	49	935
Wenjia Yang China	18	642 1.1×	310 1.1×	240 1.1×	99 0.6×	120 0.8×	59	1.1k
Matthew P. Gilbert United States	13	619 1.1×	380 1.3×	242 1.1×	78 0.5×	105 0.7×	50	993
Hasan Altunbaş Türkiye	20	525 0.9×	201 0.7×	349 1.6×	128 0.7×	69 0.5×	49	1.1k
Adriana Sánchez‐García Mexico	15	331 0.6×	151 0.5×	196 0.9×	245 1.4×	77 0.5×	36	832
Francis C. C. Chow Hong Kong	14	765 1.3×	369 1.3×	247 1.2×	117 0.7×	107 0.7×	28	1.1k
Phil Ambery United Kingdom	18	897 1.5×	449 1.6×	399 1.9×	210 1.2×	313 2.1×	57	1.3k
Thomas Hach Germany	15	827 1.4×	506 1.8×	436 2.1×	76 0.4×	182 1.2×	38	1.2k
Andrea Repaci Italy	18	556 1.0×	181 0.6×	204 1.0×	92 0.5×	61 0.4×	51	1.1k
Fone‐Ching Hsiao Taiwan	18	256 0.4×	241 0.8×	161 0.8×	165 1.0×	58 0.4×	42	848
Jun‐Sing Wang Taiwan	17	411 0.7×	226 0.8×	152 0.7×	134 0.8×	60 0.4×	93	1.0k

Countries citing papers authored by Sanbao Chai

Since Specialization

Citations

This map shows the geographic impact of Sanbao Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanbao Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanbao Chai more than expected).

Fields of papers citing papers by Sanbao Chai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanbao Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanbao Chai. The network helps show where Sanbao Chai may publish in the future.

Co-authorship network of co-authors of Sanbao Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Sanbao Chai. A scholar is included among the top collaborators of Sanbao Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanbao Chai. Sanbao Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chai, Sanbao, et al.. (2025). Evaluation of the hypoglycemic and hypotensive efficacy of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A model-based dose–response network meta-analysis. SHILAP Revista de lepidopterología. 3(2). 150–158. 1 indexed citations

Chai, Sanbao, et al.. (2024). Comparison of GLP‐1 Receptor Agonists, SGLT‐2 Inhibitors, and DPP‐4 Inhibitors as an Add‐On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review. Journal of Diabetes Research. 2024(1). 8145388–8145388. 3 indexed citations

Xiao, Jie, et al.. (2024). HTs-GCN: Identifying Hardware Trojan Nodes in Integrated Circuits Using a Graph Convolutional Network. IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 44(6). 2353–2366.

Zhao, Hou-Yu, et al.. (2024). Risk of type 2 diabetes and long-term antibiotic use in childhood: Evidence from the UK Biobank. Diabetes Research and Clinical Practice. 209. 111571–111571. 2 indexed citations

Chai, Sanbao, et al.. (2024). Triglyceride‐glycaemic index: Insights into predicting fetal macrosomia and its interaction with gestational diabetes mellitus: A cohort study of Chinese pregnant women. European Journal of Clinical Investigation. 54(12). e14300–e14300. 1 indexed citations

Zhao, Hou-Yu, Sanbao Chai, Yexiang Sun, et al.. (2024). Influence of early use of sodium-glucose transport protein 2 inhibitors, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on the legacy effect of hyperglycemia. Frontiers in Endocrinology. 15. 1369908–1369908.

Liu, Yufang, et al.. (2024). Association of visceral adipose tissue with albuminuria and interaction between visceral adiposity and diabetes on albuminuria. Acta Diabetologica. 61(7). 909–916. 3 indexed citations

Zhang, Ya-Rong, Rui Wang, Yan-Rong Yu, et al.. (2024). Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway. Pharmaceuticals. 17(9). 1204–1204. 1 indexed citations

Zuo, Li, Xianghai Zhou, Hongwei Gao, et al.. (2023). A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter Study. Journal of Diabetes Research. 2023. 1–9. 6 indexed citations

10.

Chai, Sanbao, Fengqi Liu, Shuqing Yu, Zhirong Yang, & Feng Sun. (2023). Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies. Journal of Diabetes Investigation. 14(7). 864–873. 8 indexed citations

11.

Liu, Yufang, et al.. (2023). Association Between Different Parameters of Adipose Distribution and Transient Elastography-Assessed Hepatic Steatosis in American Adults with Diabetes, Prediabetes and Normal Glucose Tolerance. Diabetes Metabolic Syndrome and Obesity. Volume 16. 299–308. 1 indexed citations

12.

Chai, Sanbao, et al.. (2021). Association Between Thyroid Hormone Levels and Advanced Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. Diabetes Metabolic Syndrome and Obesity. Volume 14. 2399–2406. 9 indexed citations

13.

Chai, Sanbao, Chen Yao, Sixu Xin, et al.. (2021). Positive Association of Leptin and Artery Calcification of Lower Extremity in Patients With Type 2 Diabetes Mellitus: A Pilot Study. Frontiers in Endocrinology. 12. 583575–583575. 12 indexed citations

14.

Yuan, Ning, Sanbao Chai, Jianbin Sun, et al.. (2020). Characteristics of Patients with Hypopituitarism having Onset Symptoms of Pseudo-Intestinal Obstruction: A Case Report. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(2). 360–364. 1 indexed citations

15.

Chai, Sanbao, et al.. (2020). The effect of education and mobile health management on improvement of blood glucose with type 2 diabetes mellitus. Journal of Public Health. 30(1). 205–209. 3 indexed citations

16.

Chai, Sanbao, Shuqing Yu, Zhirong Yang, et al.. (2019). Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks. BMJ Open Diabetes Research & Care. 7(1). e000728–e000728. 17 indexed citations

17.

Chai, Sanbao, Lin Xu, Danyang Wang, et al.. (2018). The effect of diabetes self-management education on psychological status and blood glucose in newly diagnosed patients with diabetes type 2. Patient Education and Counseling. 101(8). 1427–1432. 52 indexed citations

18.

Huang, Chao, Shanshan Wu, Yang Xu, et al.. (2017). The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials. PLoS ONE. 12(12). e0187537–e0187537. 38 indexed citations

19.

Sun, Feng, Sijia Wu, Sanbao Chai, et al.. (2014). Impact of Glp-1RA on Heart Rate, Blood Pressure and Hypertension Among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Value in Health. 17(7). A719–A720. 4 indexed citations

20.

Chai, Sanbao, et al.. (2013). Leptin and coronary heart disease: A systematic review and meta-analysis. Atherosclerosis. 233(1). 3–10. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact